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Abstract 
Purpose: To investigate the antioxidant activity of Coffea Arabica L in high-fat diet (HFD)-fed C57BL/6J 
mice. 
Methods: A decoction of Arabian coffee blended with or without cardamom or cloves was orally 
administered to HFD-fed C57BL/6J mice for a period of 60 days. At the end of the treatment, blood and 
tissue samples were taken to evaluate various parameters, including lipid peroxidation markers and 
antioxidants such as paraoxonase (PON1), superoxide dismutase (SOD), glutathione peroxidase (GPx), 
vitamin C, vitamin E, reduced glutathione (GSH) and catalase (CAT). 
Results: The activities of antioxidant enzymes (PON1, SOD, CAT, and GPx) and non-enzymatic 
antioxidants (GSH, vitamins C and E) were significantly elevated (p < 0.05) in mice administered 
Arabian coffee plus cardamom compared with those administered HFD alone or coffee alone. The 
levels of thiobarbituric reactive substances and oxidized LDL antibody (oxLDL-Ab) decreased 
significantly (p < 0.05) in mice administered Arabian coffee plus cardamom compared with those 
administered Arabian coffee plus cloves.  
Conclusion: The results indicate that Arabian coffee blended with cardamom or cloves exhibited 
enhanced free radical scavenging and antioxidant properties compared with those that received Arabic 
coffee alone. However, coffee with cardamom had more pronounced effects than coffee with cloves. 
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An epidemic of cardiovascular diseases is 
emerging; in particular, the burden of coronary 
heart disease is rising in Saudi Arabia [1]. 
Obesity is correlated with an increase in the 
number of individuals with metabolic 
abnormalities and premature cardiovascular 
disease (CVD). Many oxygenated compounds, 
particularly aldehydes, such as malondialdehyde 
(MDA), and conjugated dienes (CD), are 
produced in the body owing to increased 
generation of free radicals that damage 
membrane lipoproteins [2,3]. Hyperglycemia 
itself causes an increase in free radicals because 
of auto-oxidation and non-enzymatic protein 
glycation [2,3].  
 
Antioxidant enzymes, such as superoxide 
dismutase (SOD), catalase (CAT), and 
glutathione peroxidase (GPx), and non-
enzymatic antioxidants, such as vitamins C and 
E and reduced glutathione (GSH), play vital roles 
in alleviating tissue damage caused by the 
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accumulation of free radicals [4]. Similarly, 
paraoxonase (PON1) aryl esterase, a calcium-
dependent serum esterase, is linked with high-
density lipoproteins (HDL) that participate in 
protecting LDL from peroxidation [5]. 
 
Studies have also indicated that the low-grade 
systemic inflammatory state that occurs in those 
who are obese not only affects insulin sensitivity, 
but also reduces HDL levels and their antioxidant 
capacity [6]. Correcting low HDL antioxidant 
capacity might be important for reducing 
cardiovascular risk, particularly in diabetic 
subjects. Some pharmacological agents that are 
currently used for the treatment of type 2 
diabetes, such as sulfonylureas, biguanides, 
thiazolidinedione, and α-glycosidase inhibitors, 
are limited by their side effects and failure to alter 
diabetic complications. Innumerable natural 
sources are yet to be explored for this purpose.  
 
Coffee is highly consumed [7]. People in Saudi 
habitually enjoy consuming Arabian coffee made 
from lightly roasted Arabian coffee beans mixed 
with cardamom [8]. A clear understanding of the 
effects of coffee on health is vital for making 
informed choices about coffee consumption. 
Some studies suggested that coffee consumption 
reduced the risk of developing Alzheimer’s 
disease, Parkinson’s disease, and prostate 
cancer [9,10]. In addition, long-term coffee 
consumption may be associated with a 
decreased risk of developing type 2 diabetes 
[11]. Importantly, oxidative stress is a prime 
factor that links hyperlipidemia and diabetes in 
the pathogenesis of atherosclerosis. In this 
study, the antioxidant activity of Arabian coffee 
(prepared via traditional methods) was evaluated 






Trichloroacetic acid, hydrochloric acid, 
thiobarbituric acid, nitroblue tetrazolium, 
potassium dichromate, and all other analytical 
grade chemicals and reagents were procured 
form Merck Ltd (Germany), Sigma-Aldrich Ltd 
(USA), and Himedia Ltd (India). Coffee seeds, 
cardamom, and cloves were purchased from a 
domestic market in Riyadh, Saudi Arabia.  
 
Preparation of Arabian coffee  
 
In this study, a mixture of Arabian coffee was 
prepared without sugar, creamer, or milk as 
follows. Coffea Arabica L beans were roasted for 
10 min, then powdered. Thirty grams of coffee 
powder was mixed with 1 L of water and the 
mixture was boiled for 3–5 min, left at room 
temperature for 2 min, and then filtered. The 
mixture was stored at room temperature for 
further use. The protocol for preparing the 
decoction was adapted from previous papers 
[12]. Separate decoctions were prepared with 2.5 
g of ground cardamom, cloves, or both.  
 
Animals and diet 
 
Male C57BL/6J mice (5 weeks old), weighing 20 
to 30 g, were procured from Animal Care of 
Saudi Arabia, Saudi. The mice were maintained 
in an air-conditioned room (25 ± 1°C) with a 12 h 
light/12 h dark cycle in the animal house at the 
College of Medicine, King Saud University. Mice 
were provided feed and water ad libitum. The 
study was conducted according to the 
international guidelines of the Committee for the 
Purpose of Control and Supervision of 
Experiments on Animals [13] and was approved 
by Institutional Animals Ethics Committee of 
Experimental Animal Care Center, College of 
Pharmacy (reg. no. 108-EACC-2015), King Saud 
University, approved the study protocol. 
 
The animals were divided into 6 groups of 6 
animals each. Mice were fed a standard diet for 
the first 2 weeks. The standard diet contained 
crude protein (22.12%), crude oil (4.12%), crude 
fiber (3.18%), ash (5.17%), and sand silica 
(1.13%) with an energy value of 3625 kcal/kg.   
 
The experimental groups and the diets 
administered are as indicated in Table 1.  
 
Group Diet 
I A standard pellet diet and water 
ad libitum  
II A standard pellet diet and water 
ad libitum +  Plain Arabian coffee 
III HFD alone 
IV HFD + Arabian coffee + 
cardamom 
V HFD + Arabian coffee + 
cardamom + cloves 




The mice were fed their respective diets orally. 
The total experimental duration spanned 60 
days. At the end of the treatment, the animals 
were anaesthetized with ketamine (24 mg/kg 
body weight, intramuscular injection) and killed 
via decapitation. Blood was collected from the 
jugular vein. Serum and plasma were obtained 
after centrifugation and used for various 
biochemical evaluations. Tissues were 
removed, cleared of blood, and immediately 
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transferred to ice-cold containers, homogenized 
in appropriate buffer, and used to evaluate 
various parameters as indicated below. 
 
Determination of lipid peroxidation and 
antioxidants 
 
Thiobarbituric acid reactive substances 
(TBARS) 
 
The concentration of TBARS was estimated 
using the method described by Ohkawa [14]. In 
this method, malondialdehyde and other TBARS 
were reacted with thiobarbituric acid in acidic 
conditions to generate a pink chromophore, the 




SOD activity was assayed using the method 
described by Kakkar et al [15]. The assay is 
based on inhibition of the formation of NADH-
phenazinemethosulfate, nitroblue tetrazolium 
formazan. The reaction was initiated by adding 
NADH to the assay mixture. After incubation for 
90 s, glacial acetic acid was added to stop the 
reaction. The color developed at the end of the 
reaction was extracted into the n-butanol layer 




CAT activity was determined using the method 
described by Sinha [16]. Dichromate in acetic 
acid was converted to perchromic acid and then 
to chromic acetate when heated in the presence 
of H2O2. The chromic acetate formed was 
measured at 620 nm. The CAT preparation was 
allowed to split H2O2 for various periods of time. 
The reaction was stopped at different time 
intervals by adding dichromate-acetic acid 
mixture and the remaining H2O2 as chromic 




The activity of GPx was measured using the 
method described by Rotruck et al [17]. A known 
amount of enzyme preparation was allowed to 
react with H2O2 in the presence of GSH for a 
specified period, and then, the remaining amount 




The levels of GSH were estimated using the 
method described by Ellman [18]. This method 
was based on the formation of 2-nitro-5-
thiobenzoic acid (a yellow colored compound) 
when 5, 5′-dithio-bis (2-nitrobenzoic acid) 
(DTNB) was added to compounds containing 
sulfhydryl groups. 
 
Vitamin C  
 
The levels of ascorbic acid (vitamin C) were 
estimated using the method described by Roe 
and Kuether [19]. The ascorbic acid was 
converted to dehydroascorbic acid by mixing with 
norit and then coupled with 2,4-
dinitrophenylhydrazine (DNPH) in the presence 
of thiourea, a mild reducing agent. The coupled 
dinitrophenylhydrazine was converted to a red 
compound when treated with sulfuric acid. 
 
Vitamin E   
 
The levels of –tocopherol were estimated by 
the method described by Baker et al [20]. The 
method involves reducing ferric ions to ferrous 
ions using -tocopherol and the formation of a 
red complex with 2, 2′ dipyridyl. Absorbance of 
the chromophore was measured at 520 nm. 
 
Oxidized LDL antibody (oxLDL Ab) 
 
The levels of oxLDL Ab were estimated using an 
ImmuLisa Oxidized LDL antibody ELISA kit 
(IMMCO Diagnostics). PON1 arylesterase 
activity was measured using a method adapted 




Statistical evaluation was performed using one-
way analysis of variance (ANOVA), which was 
followed Duncan’s multiple range test (DMRT). 
The analyses were conducted using SPSS 16.0. 
The significance level was set at  




Effect of Arabian coffee, cardamom, and 
cloves on the levels of plasma and tissue 
TBARS 
 
Table 1 shows the effect of Arabian coffee, 
cardamom and cloves on the levels of TBARS in 
the plasma and tissues of HFD-fed C57BL/6J 
mice. The HFD-fed mice exhibited elevated 
levels of TBARS. The administration of Arabian 
coffee, cardamom and cloves resulted in a 
significant reduction in the levels of TBARS. This 
effect was more pronounced in mice 
administered Coffea Arabica L plus cardamom. 
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Table 1: Effect of Arabian coffee, cardamom and cloves on the levels of TBARS in the erythrocyte and tissues of 







Liver Kidney Heart 
Control  0.18 ± 0.1a 0.78± 0.03a 1.46± 0.11a 0.55± 0.04a 
Control + Arabian coffee 0.16 ± 0.01a 0.77± 0.02a 1.39± 0.09a 0.49± 0.03a 
HFD 0.50 ± 0.04b 2.01± 0.08b 3.48 ± 0.25b 1.90± 0.17b 
HFD + Arabian coffee + Cardamom 0.32 ± 0.03c 1.42± 0.06c 2.39± 0.17c 1.05± 0.07c 
HFD + Arabian coffee + Cardamom + cloves 0.23 ± 0.02a,d 0.95 ± 0.06d 2.03± 0.15d 0.91± 0.06c,d 
HFD + coffee with cloves 0.29 ± 0.03c,e 1.21± 0.05e 2.23± 0.16e 1.02± 0.07c,e 
Values are means SD for six samples from 6 mice in each group; Values not sharing a common superscript 
differ significantly at p ≤ 0.05. Duncan’s Multiple Range Test (DMRT) 
Table 2: Effect of Arabian coffee, cardamom and cloves on the activity of superoxide dismutase in the 






Superoxidedismutase  (U@/mg protein) 
Liver Kidney Heart 
Control  8.47 ± 0.25a 7.90± 0.51a 14.92 ± 0.60a 6.52± 0.33a 
Control + Arabian coffee 7.75 ± 0.19a 8.98 ± 0.61a 13.03 ± 1.39a 5.25± 0.22a 
HFD 3.58 ± 0.32b 4.50 ± 0.40b 7.98 ± 0.35b 3.69± 0.33b 
HFD + Arabian coffee + Cardamom 6.25 ± 0.61a,c 5.10± 0.65c 10.42 ± 0.97c,d 4.20± 0.19c 
HFD + Arabian coffee + Cardamom + cloves 8.09 ± 0.49a,c 6.92 ± 0.63c 13.20 ± 0.26a,c 5.19 ± 0.37c,e 
HFD + coffee with cloves 7.54 ± 0.58c 5.69± 0.40d 12.29 ± 0.73d 4.98± 0.31d 
Values are means SD for six samples from 6 mice in each group; Values not sharing a common superscript 
differ significantly at p ≤ 0.05. Duncan’s Multiple Range Test (DMRT); U@= Enzyme concentration required for 
50 % inhibition of NBT reduction/minute 
 
Table 3: Effect of Arabian coffee, cardamom and cloves on the activity of catalase in the erythrocyte and tissues 






CAT  (U*/mg protein) 
Liver Kidney Heart 
Control  171.75 ± 2.56a 79.36 ± 6.71a 35.34 ± 2.93a 50.36 ± 3.03a 
Control + Arabian coffee 173.21 ± 7.60a 80.81 ± 7.84a 36.94 ± 3.12a 51.99 ± 3.52a 
HFD 104.81 ± 6.62b 45.78 ± 2.64b 17.83 ± 1.33b 26.63 ± 2.02b 
HFD + Arabian coffee + Cardamom 150.63 ± 3.74c 60.30 ± 1.35c 25.32 ± 2.12c,d 34.96 ± 2.57c 
HFD + Arabian coffee + Cardamom + cloves 166.62 ± 5.53e 75.20 ± 2.40e 32.42 ± 1.82c 48.56 ± 2.81e 
HFD + coffee with cloves. 153.24 ± 4.28d 65.32 ± 1.59d 28.51 ± 2.45d 42.32 ± 3.25d 
Values are means   SD for six samples from 6 mice in each group; Values not sharing a common superscript 
differ significantly at p ≤ 0.05. Duncan’s Multiple Range Test (DMRT); U*- μmol of H2O2 consumed/min 
 
Effect of Arabian coffee, cardamom, and 
cloves on enzymatic and non-enzymatic 
antioxidants in erythrocytes and tissues of 
HFD-fed C57BL/6J mice 
 
Table 2, Table 3, and Table 4 show the effect of 
Coffea Arabica L, cardamom and cloves on the 
activities of SOD, CAT, and GPx in the 
erythrocytes and tissues of HFD-fed mice. The 
activities of SOD, CAT, and GPx significantly 
decreased in HFD-fed mice and the consumption 
of Coffea Arabica L plus cardamom resulted in a 
significant increase in these enzymes. 
 
Table 5, Table 6 and Table 7 show the effect of 
Coffea Arabica L, cardamom, and cloves on the 
levels of vitamin C, vitamin E, and GSH in the 
erythrocytes and tissues of HFD-fed C57BL/6J 
mice. The levels of vitamin C, vitamin E, and 
GSH decreased significantly in HFD-fed mice 
and groups administered Coffea Arabica L, 
cardamom and cloves significantly exhibited 
increases in these parameters. 
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Table 4: Effect of Arabian coffee, cardamom and cloves on the activity of glutathione peroxidase in the 







Liver Kidney Heart 
Control  16.21 ± 1.19a 9.25 ± 0.88a 10.85 ± 0.75a 8.25 ± 0.35a 
Control + Arabian coffee 15.53 ± 1.24a 10.56 ± 0.66a 11.04 ± 0.39a 8.56 ± 0.62a 
HFD 6.85 ± 0.67b 5.86 ± 0.38b 5.84 ± 0.55b 4.77 ± 0.21b 
HFD + Arabian coffee + Cardamom 11.75 ± 0.75c,d 6.21 ± 0.34c,d 7.02 ± 0.44c 5.90 ± 0.62c 
HFD + Arabian coffee + Cardamom + cloves 15.65 ± 0.40e 8.71 ± 0.72c 9.56 ± 0.41e,c 7.30 ± 0.56e,c 
HFD + coffee with cloves. 13.61 ± 1.67d 7.26 ± 0.45d 8.53 ± 0.69d 6.43 ± 0.41d 
Values are means SD for six samples from 6 mice in each group; values not sharing a common superscript 
differ significantly at p ≤ 0.05. Duncan’s Multiple Range Test (DMRT); U*- μg of GSH utilized/min 
  
Table 5: Effect of Arabian coffee, cardamom and cloves on vitamin C in the plasma and tissues of HFD-fed 
C57BL/6J mice 
 
Group Plasma Vitamin C (mg/dL) 
Vitamin C (µg/mg protein) 
Liver Kidney Heart 
Control  2.46± 0.16a 0.85± 0.02a 0.83 ± 0.04a 0.60 ± 0.04a 
Control + Arabian coffee 2.92 ±  0.28a 0.89± 0.07a,e 0.85 ± 0.06a 0.62 ± 0.05a 
HFD 0.80± 0.07b 0.55± 0.04b 0.46± 0.04b 0.39 ± 0.02b 
HFD + Arabian coffee + Cardamom 1.81± 0.17c 0.71 ± 0.05c 0.71± 0.06c,d 0.41 ± 0.04c,d 
HFD + Arabian coffee + Cardamom + 
cloves 2.18 ± 0.19
d 0.79± 0.03c,e 0.81± 0.03a,c 0.55 ± 0.03a,c 
HFD + coffee with cloves 1.89± 0.14c 0.71± 0.03d 0.74 ± 0.03d 0.46 ± 0.03d 
Values are means SD for six samples from 6 mice in each group. Values not sharing a common superscript 
differ significantly at p ≤ 0.05. Duncan’s Multiple Range Test (DMRT) 
 
Table 6: Effect of Arabian coffee, cardamom and cloves on vitamin E in the plasma and tissues of HFD-fed 
C57BL/6J mice 
 
Group Plasma Vitamin E (mg/dL) 
                           Vitamin E (µg/mg protein) 
Liver Kidney Heart 
Control  1.90 ± 0.06a 6.40± 0.41a 4.61 ± 0.35a 5.48 ± 0.37a 
Control + Arabian coffee 1.99 ± 0.08a 7.01± 0.36a 4.73± 0.28a 4.80 ±.0.27a 
HFD 0.89 ± 0.04b 3.72± 0.17b 1.52 ± 0.16b 2.77 ± 0.14b 
HFD + Arabian coffee + Cardamom 1.57± 0.04c 5.66 ± 0.29c 3.62 ± 0.13C 3.99± 0.28C 
HFD + Arabian coffee + Cardamom + cloves 1.73 ± 0.11e 5.99 ± 0.46d,e 4.23± 0.30d,e 5.19 ± 0.36d,e 
HFD + coffee with cloves 1.60 ± 0.10d 5.75± 0.34d 4.03 ± 0.29d 4.40 ± 0.38d 
Values are means SD for six samples from 6 mice in each group; Values not sharing a common superscript 
differ significantly at p ≤ 0.05. Duncan’s Multiple Range Test (DMRT) 
 
Table 7: Effect of Arabian coffee, cardamom and cloves on reduced glutathione in the plasma and tissues of 
HFD-fedC57BL/6J mice 
 
Group Plasma GSH (mg/dL) 
GSH (µg/mg protein) 
Liver Kidney Heart 
Control  31.22 ±2.41a 10.98±0.79a 11.12 ± 0.72a 9.22 ± 0.42a 
Control + Arabian coffee 30.83 ± 2.52a 11.56± 0.72a 10.56± 0.75a 9.37± 0.61a 
HFD 17.73 ±1.11b 8.52 ± 0.61b 5.56 ± 0.15b 5.50 ± 0.40b 
HFD + Arabian coffee + Cardamom 26.73 ± 1.51c  9.71 ± 0.35c 7.95± 0.61c 6.78 ± 0.62c 
HFD + Arabian coffee + Cardamom + cloves 29.91 ± 1.74a,d 10.11 ± 0.54d,c 9.67 ± 0.49d 8.57 ± 0.62d,a 
HFD + coffee with cloves 27.29 ±1.16c,d 9.76 ± 0.77d 8.78± 0.55d 7.92± 0.64d,a   
Values are means  SD for six samples from 6 mice in each group; Values not sharing a common superscript 
differ significantly at p ≤ 0.05. Duncan’s Multiple Range Test (DMRT) 
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Table 8: Effect of Arabian coffee, cardamom and cloves on the levels of oxLDL-Ab and PON aryl esterase 
activities in the plasma of HFD-fed C57BL/6Jdiabetic mice 
 
Groups PON1 aryl esterase activity (U/mg protein) 
oxLDL-Ab 
(EU/mL) 
Control  58.87 ±4.41a 18.17 ±2.41a 
Control + Arabian coffee 32.12± 2.12c 30.12± 2.12a 
HFD 18.73 ±1.41e 39.13±1.87d 
HFD + Arabian coffee + Cardamom 39.78± 1.88b 26.78± 1.88b 
HFD + Arabian coffee + Cardamom + cloves 28.91 ± 1.24d 29.91 ± 1.09c 
HFD + coffee with cloves 27.01±1.06d 28.11±1.11c 
Values are means SD for six samples from 6 mice in each group; Values not sharing a common superscript 
differ significantly at p ≤ 0.05. Duncan’s Multiple Range Test (DMRT) 
 
Effect of Arabian coffee, cardamom, and 
cloves on the levels of plasma oxLDL Ab and 
PON1 arylesterase activity in the plasma of 
HFD-fed mice 
 
Table 8 shows the effect of Coffea Arabica L, 
cardamom and cloves on the levels of plasma 
oxLDL Ab and PON1 activity in the plasma of 
HFD-fed mice. The levels of oxLDL Ab 
increased, whereas PON1 activity decreased 
significantly in HFD-fed mice. In the groups 
consuming Coffea Arabica L, cardamom and 
cloves, these parameters were similar to those of 
the non-HFD-fed control group. The effect was 





Administration of a HFD is a well-established 
method for altering the antioxidant defense 
mechanism against lipid peroxidation. Lipid 
peroxidation and non-enzymatic glycosylated 
proteins are sources of free radicals, including 
superoxide and hydrogen peroxide [22], which 
are responsible for a weakened antioxidant 
defense system in those with hyperlipidemia. 
Free-radical-scavenging enzymes (SOD, CAT, 
and GPx) are part of a preliminary defense 
mechanism, which is involved in eliminating 
superoxide anions and hydrogen peroxide. In the 
present study, administration of a HFD 
supplemented with Arabian coffee resulted in a 
significant elevation in enzymatic antioxidants. 
This result indicated that the compounds present 
in the decoction protected the tissues from lipid 
peroxidation owing to their antioxidant ability and, 
consequently, allowed for a reduction in lipid 
peroxidation. Studies have shown that oxLDL 
plays an important role in the progression of 
atherosclerosis, which results from abnormal lipid 
levels [23,24]. Elevated levels of oxLDL Ab 
indicate an accelerated atherosclerotic process. 
PON1 prevents LDL oxidation, which is an initial 
step in the development of atherosclerosis 
[25,26]. This evidence indicates that decreased 
PON1 activity is associated with increased lipid 
peroxidation in diabetes and that it might be a 
factor determining the predisposition to 
complications of diabetes. LDL particles are 
protected from oxidation in plasma by the 
antioxidant enzyme PON1, whereas LDL 
particles trapped within artery walls are prone to 
oxidative damage [27]. Tocopherol is the most 
active form of vitamin E and the most abundant 
lipid-soluble antioxidant in LDL [28]. α-
Tocopherol may also act as a phase-transfer 
agent. However, it was reported that ascorbate 
inhibited the tocopheroxyl radical (α-Toc-O•) [27].  
 
Low levels of vitamin C, vitamin E, PON1, and 
GSH in HFD-fed mice, along with increased 
oxLDL Ab levels, represented the hallmark of 
atherosclerosis. Low levels of vitamin E in HFD-
fed mice could be due to an increased utilization 
of vitamin E for scavenging radicals or to 
decreased levels of vitamin C because there is a 
well-established synergism between vitamins C 
and E [29]. Depletion of GSH in HFD-fed mice is 
likely due to consumption of GSH by electrophilic 
compounds like lipoperoxidation aldehydes. 
Treatment with Arabian coffee increased 
antioxidants and reduced lipid peroxidation and 
oxLDL Ab levels. Moreover, a reduction in 
plasma oxLDL Ab levels and elevation of PON1 
activity in Arabian coffee-treated mice indicated 
that Arabian coffee improved the antioxidant 




The antioxidant properties of Arabian coffee, as 
indicated in this study, support its traditional 
medicinal use in Saudi and several other parts of 
the world. In addition, as inferred from the 
results, Arabian coffee plus cardamom exhibited 
potential antioxidant properties and counteracted 
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